Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene Analyses

Pouria Momayyezi1, Karl-Johan Malmberg1,2, Quirin Hammer1

  • 1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Current Protocols
|November 28, 2022
PubMed

Insights

This study presents a straightforward method for delivering small interfering RNA (siRNA) into human natural killer (NK) cells. This technique enhances gene function analysis in NK cells, crucial for cancer immunotherapy research.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Understanding gene functions in human natural killer (NK) cells is vital for advancing NK cell biology and cancer immunotherapy.
  • Current methods for gene manipulation in NK cells face challenges with delivery efficiency and cell viability.

Purpose of the Study:

  • To develop a simple and effective workflow for delivering small interfering RNA (siRNA) into primary human NK cells.
  • To facilitate functional gene analyses in NK cells for improved understanding and therapeutic applications.

Main Methods:

  • Enrichment of NK cells from peripheral blood mononuclear cells (PBMCs).
  • Preparation of siRNA molecules.
  • Delivery of siRNA into primary human NK cells using a novel workflow.
  • Protocols for cell isolation, thawing, purity assessment, and knockdown efficiency evaluation are detailed.

Main Results:

  • A reproducible workflow for delivering siRNA into primary human NK cells was established.
  • The method enables effective gene silencing for functional studies in NK cells.
  • Improved viability and delivery efficiency compared to traditional methods.

Conclusions:

  • The developed workflow simplifies gene function analysis in human NK cells.
  • This advancement supports the development of improved NK cell-based cancer therapies.
  • The protocol provides a valuable tool for researchers in immunology and cell therapy.